Source 20240722_182742
Canonical Links
| item | link |
|---|
| Direct transcription | 20240722_182742 |
| Raw photo | data/raw/photos/20240722_182742.jpg |
| field | value |
|---|
| Page label | Page 446 of 453 |
| Navigation path | Pipeline of GD & GBA-PD > Supplement > Other Biobanks > Biobanks in Japan > BIOMARKER > BioOrchestra > CEI > Summary CEI |
| Section | GBA-PD, GD, and α-Synuclein Pipeline |
| Uncertain spans | 3 |
| Embedded images | 0 |
| Related photos | 2 |
Headings
- Tx Nurr1:RXRa BRF110 program tail (TE / Neuroprotection / aSyn / neuroinflammation rows), Seelos / Herophilus / Myro Tx / AcureX / VesperBio / Priavoid / D&D Pharma (Neuraly), GLP-1R agonists clinical trials table, Summary CEI section opener
- Tx — Nurr1:RXRa program (BRF110)
- Companies CEI
- Summary CEI
- Projects in DD/Partnering Discussions:
- Uncertain Spans
Wiki Coverage
Topic-level synthesis should link back to this source note or directly to the canonical transcription when making specific claims.